Thiopropazate
| Thiopropazate | |
|---|---|
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Thiopropazate is a typical antipsychotic medication used in the treatment of schizophrenia and other psychotic disorders. It belongs to the class of drugs known as phenothiazines, which are known for their antipsychotic and antiemetic properties.
Medical Uses[edit]
Thiopropazate is primarily used to manage symptoms of schizophrenia, including hallucinations, delusions, and disordered thinking. It may also be used in the treatment of severe nausea and vomiting.
Mechanism of Action[edit]
Thiopropazate works by blocking dopamine receptors in the brain, particularly the D2 receptors. This action helps to reduce the effects of excess dopamine, which is thought to contribute to the symptoms of psychosis.
Side Effects[edit]
Common side effects of thiopropazate include drowsiness, dry mouth, constipation, and blurred vision. More serious side effects can include tardive dyskinesia, a condition characterized by involuntary, repetitive body movements, and neuroleptic malignant syndrome, a potentially life-threatening condition.
Pharmacokinetics[edit]
Thiopropazate is metabolized in the liver and excreted primarily through the kidneys. The drug's half-life and other pharmacokinetic properties can vary depending on the individual patient.
History[edit]
Thiopropazate was developed in the mid-20th century as part of the search for effective treatments for schizophrenia and other psychotic disorders. It is one of many phenothiazine derivatives that have been used in psychiatric medicine.
See Also[edit]
References[edit]
 | This medical article is a stub. You can help WikiMD by expanding the page. |
